Edwards MITRIS RESILIA Valve Receives CE Mark for Mitral Replacement Surgeries
Edwards Lifesciences today announced it received CE Mark for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart's mitral position.
- Edwards Lifesciences today announced it received CE Mark for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart's mitral position.
- The MITRIS RESILIA valve is made with innovative bovine pericardial tissue technology that reduces calcium build up on the valve.
- View the full release here: https://www.businesswire.com/news/home/20231025088486/en/
The MITRIS RESILIA valve is made with innovative tissue technology RESILIA allowing the valve to potentially last longer than conventional bioprosthetic valves. - * (Photo: Business Wire)
The MITRIS RESILIA valve has a saddle-shaped sewing cuff that mimics the asymmetric shape of the native mitral valve.